7 min read By Staff, Stack Bulletin

How long does lion's mane take to work? Eight trials timed

One human trial tracked lion's mane for months and first found a difference at week 8. Single doses at 60 to 120 minutes split. Eight trials, timed.


It depends what you mean by working. In the eight human lion’s mane trials this desk read, the only one that tracked change over months, in 30 older adults with mild cognitive impairment, first found a difference from placebo at week 8. Single doses tested at 60 to 120 minutes split, and so did the four-week trials.

That is the evidence behind the question “how long does lion’s mane take to work”, and it is thinner than a supplement tub suggests. This desk read the eight trial abstracts through PubMed’s E-utilities on 23 October 2026. The researcher’s PubMed search for placebo-controlled or randomised human studies of Hericium erinaceus returned 11 records, so eight trials is what we read, not every study that exists.

How long does lion’s mane take to work in the trials?

There are three different answers, because the trials asked three different questions.

Within two hours of one dose. Three trials looked here. Docherty 2023 gave 1.8 g to 41 healthy adults aged 18 to 45, who were quicker on the Stroop task 60 minutes later (p = 0.005). A 2023 Nutrients crossover tested 1 g of Nordic-grown lion’s mane at one and two hours and reported better Serial 7s attempts and N-Back reaction time. The Frontiers in Nutrition 2025 crossover, 3 g of a 10:1 fruiting-body extract, found no significant effect on composite cognition or mood at 90 minutes, only a better pegboard score.

After four weeks of daily use. Four trials ran about a month. Two leaned positive, at best weakly: Docherty’s stress score was a trend that missed significance, and a cookie trial in women moved mostly against its own baseline. The other two, a 10 g muffin trial and the newest pilot, were null.

Over months. Only Mori 2009 reports change at several points, and it is where the “eight weeks” figure comes from.

What did each trial time?

Every cell is from the abstract, not the full paper.

Trial (PMID)Dose and formWhoWhen measuredDifference found?
Docherty 2023 (38004235)1.8 g41 healthy adults, 18-4560 min; 28 daysStroop quicker at 60 min; stress trend at 28 days (p = 0.051)
Nutrients 2023 (38140277)1 g Nordic extract, one doseHealthy adults, crossover1 h and 2 hSerial 7s attempts and N-Back reaction time improved
Front Nutr 2025 (40276537)3 g of 10:1 extract, one dose18 healthy adults, 18-3590 minNo composite effect; pegboard only
Nagano 2010 (20834180)Cookies; dose not stated30 women4 weeksLower than baseline; two complaint items beat placebo
Int J Exerc Sci 2022 (36582308)10 g a day in muffins24 participants4 weeksNone (all p > 0.05)
Evans 2026 (42884628)2 g a day, mycelium plus fruiting body10 healthy adults, 18-5528 days, pre-postNone (p > 0.05)
Saitsu 2019 (31413233)Fruiting-body supplement; dose not statedNot stated in abstract12 weeksMMSE only
Mori 2009 (18844328)Four 250 mg tablets, three times a day30 adults, 50-80, mild cognitive impairmentWeeks 8, 12, 16; 4 weeks after stoppingYes at weeks 8, 12, 16; fell after stopping

Why is eight weeks the number people quote?

Because it is the first point at which the one long, placebo-controlled trial reported a result. Mori’s 30 participants took twelve 250 mg tablets a day, each 96% dry Yamabushitake powder, for 16 weeks. “At weeks 8, 12 and 16”, the abstract says, the lion’s mane group scored significantly higher on a cognitive scale than placebo, and scores rose with duration.

Two caveats travel with that number. The abstract does not report any measurement between baseline and week 8, so it cannot tell you whether something changed at week 4. And the people were older Japanese adults with diagnosed mild cognitive impairment, not healthy thirty-year-olds. The lead author’s listed affiliation is Hokuto Corporation’s mushroom laboratory.

Saitsu 2019 ran 12 weeks and found an improvement on the MMSE alone, of three tests, but its abstract gives no dose, no sample size and no interim timepoints, so it adds nothing to the onset question.

Does the form or dose change the timeline?

The table cannot answer that, and it is worth saying why. The trials used different preparations: tablets of dry powder, cookies, muffins, a 10:1 fruiting-body extract, a Nordic-grown extract and a mycelium-and-fruiting-body blend, at stated amounts from 1 g to 10 g. No two trials share a dose, a form and a population, so no pair isolates whether a stronger extract works sooner. The largest daily amount, 10 g in muffins, produced nothing measurable at four weeks; the smallest single dose, 1 g, was followed by task changes within two hours. That is not a dose-response. It is two different experiments.

Does it work faster in healthy adults?

The eight abstracts this desk read do not settle it. The one-dose results point in different directions, and the effects that did appear were on single tasks, not overall scores. The Frontiers authors conclude that any benefits “may be task or domain specific”.

The four-week picture is no clearer. Nagano’s cookie trial found depression and complaint scores lower than before, but against placebo only two items of the complaints index, “insentive” and “palpitatio”, differed. The 10 g muffin trial found no significant effect on any measure (all p > 0.05).

The newest data point is Evans et al., published in Nutrients on 26 September 2026. Ten healthy adults took 2 g a day for 28 days, compared against their own baseline with no placebo arm described in the abstract, and showed no statistically significant change in executive function or plasma BDNF. The authors read small-to-moderate effect sizes as a promising signal; a ten-person pilot without significance is not a benefit. Its author affiliations include Substantiation Sciences, LLC.

Industry ties run through the field: the Frontiers 2025 author list includes Beyond Alcohol Ltd as an affiliation, and Sempera Organics supplied Docherty’s product. We did not read who funded the 2023 Nordic study.

For the same question asked of another ingredient, see how long bacopa takes to work. Time of day is a different question, covered in when to take lion’s mane, and the doses behind each row are in our dose post.

Questions readers ask

Does lion’s mane work immediately?

Sometimes, on one task, in some trials. A single 1.8 g dose made healthy young adults quicker on the Stroop task 60 minutes later, and a 1 g Nordic extract improved Serial 7s attempts and N-Back reaction time in a test window of one to two hours. But a 3 g extract changed no composite measure of cognition or mood at 90 minutes. Nothing here shows a reliable effect you would feel.

How long does it take for lion’s mane to start working?

The only trial we read that measured change over months, Mori 2009, first reported a difference from placebo at week 8, in 30 adults aged 50 to 80 with mild cognitive impairment. Its abstract does not report an earlier measurement, so week 8 is when it first looked, not proof nothing happened sooner. For healthy young adults, the four-week trials split and give no dependable timeline.

How do you know if lion’s mane is working?

The trials did not rely on feeling. They used scored tests: a dementia screening scale, the Stroop task, card sorts, depression and stress questionnaires, compared with placebo. A reader at home has no placebo group, so a sense of sharper focus after a week is hard to separate from expectation. In one 2023 trial, the placebo group also reported better focus an hour after dosing.

What happens when you stop taking lion’s mane?

In the one trial we read that followed people after they stopped, the gain did not hold. In Mori 2009, cognitive scores in the lion’s mane group had risen across 16 weeks, then decreased significantly by week 4 after intake ended. That is one 30-person study in older adults with mild cognitive impairment, so it says nothing certain about healthy users.

Where this leaves the label-reader

A tub that promises results “in weeks” is borrowing a number from one small trial in older adults with mild cognitive impairment, and that trial’s gains faded once intake stopped. If a label quotes a timeline, ask which study, at what dose, in whom. None of this is medical advice. Lion’s mane is sold as an adult supplement not intended to diagnose, treat, cure or prevent any disease; anyone on medication should ask a clinician first.